Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Bortezomib/melphalan/prednisone

Pneumonia and deep vein thrombosis of the leg

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Krecak I, et al. REFRACTORY GUILLAIN-BARRE SYNDROME IN A PATIENT WITH ASYMPTOMATIC MULTIPLE MYELOMA SUCCESSFULLY TREATED WITH LOW-DOSE RITUXIMAB. Acta Clinica Croatica 62: 382-386, No. 2, Jan 2023. Available from: URL: https://dx.doi.org/10.20471/acc.2023.62.02.19 Krecak I, et al. REFRACTORY GUILLAIN-BARRE SYNDROME IN A PATIENT WITH ASYMPTOMATIC MULTIPLE MYELOMA SUCCESSFULLY TREATED WITH LOW-DOSE RITUXIMAB. Acta Clinica Croatica 62: 382-386, No. 2, Jan 2023. Available from: URL: https://​dx.​doi.​org/​10.​20471/​acc.​2023.​62.​02.​19
Metadaten
Titel
Bortezomib/melphalan/prednisone
Pneumonia and deep vein thrombosis of the leg
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49462-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs